APLT
Applied Therapeutics Inc
NASDAQ: APLT · HEALTHCARE · BIOTECHNOLOGY
$0.10
+0.00% today
Updated 2026-04-29
Market cap
$14.86M
P/E ratio
—
P/S ratio
14.86x
EPS (TTM)
$-0.10
Dividend yield
—
52W range
$0 – $2
Volume
2.7M
Applied Therapeutics Inc (APLT) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $3.29M | $20.25M | $48.39M | $104.51M | $89.89M | $38.36M | $54.83M | $86.69M |
| Cash & equivalents | $3.28M | $18.75M | $18.85M | $57.47M | $53.89M | $16.66M | $49.90M | $79.40M |
| Current assets | $3.29M | $20.25M | $46.16M | $102.59M | $88.39M | $37.31M | $54.39M | $83.65M |
| Total liabilities | $7.25M | $4.43M | $15.78M | $22.57M | $27.35M | $34.30M | $71.98M | $29.68M |
| Current liabilities | $993000.00 | $4.43M | $14.10M | $21.23M | $26.46M | $33.42M | $71.18M | $27.30M |
| Long-term debt | $0.00 | $0.00 | — | — | — | $464000.00 | — | — |
| Shareholder equity | $-3.96M | $15.82M | $32.61M | $81.94M | $62.54M | $4.06M | $-17.15M | $57.01M |
| Retained earnings | $-4.74M | $-21.26M | $-66.77M | $-160.73M | $-266.31M | $-348.82M | $-468.59M | $-574.21M |
| Accounts receivable | — | — | — | $505000.00 | $525000.00 | $275000.00 | $285000.00 | — |
| Inventory | $0.00 | $0.00 | — | $-505000.00 | $-525000.00 | $5.32M | $3.28M | — |
| Goodwill | $0.00 | $0.00 | — | — | — | — | — | — |